Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications

Area of Science:

• Endocrinology
• Immunology
• Nanomedicine

Background:

• Autoimmune thyroid diseases (AITDs) are T cell-mediated disorders resulting from immune dysregulation attacking thyroid tissue.
• Key forms include autoimmune thyroiditis and Graves' disease, presenting as hypothyroidism and thyrotoxicosis, respectively.
• Etiopathogenesis involves genetic susceptibility and environmental factors.

Purpose of the Study:

• To review the application of nanomedicine in diagnosing and treating thyroid disorders.
• To explore nanomedicine's role in developing sensitive diagnostic methods and novel therapeutic approaches for AITDs.

Main Methods:

• Review of studies utilizing nanomedicine for nanodiagnosis, nanotherapy, and nanotheranostics in thyroid disorders.
• Analysis of nanomedicine applications for detecting TSH, iodine, and TSAb.
• Examination of nanomedicine-based treatments for autoimmune thyroiditis, Graves' disease, and thyroid eye disease.

Main Results:

• Nanomedicine has enabled sensitive detection methods for key thyroid-related markers.
• Nanomedicine approaches are being explored for novel treatments of various AITDs.
• Theranostic applications are emerging for integrated diagnosis and therapy.

Conclusions:

• Nanomedicine presents a promising frontier for advancing the diagnosis and treatment of AITDs.
• Future nanomedicine applications will likely be personalized based on genetic profiles.
• Personalized nanomedicine aims to enhance therapeutic effectiveness and minimize side effects for better patient outcomes.